Analysts Issue Forecasts for ATXS Q1 Earnings
Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) – Stock analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Astria Therapeutics in a report issued on Tuesday, March 11th. HC Wainwright analyst J. Pantginis anticipates that the biotechnology company will post earnings of ($0.50) per share for the quarter. HC […]
